Evidence map›Paper›PMID 39014402›Full record

ArticleJournal of nanobiotechnology2024

Endogenous and exogeneous stimuli-triggered reactive oxygen species evoke long-lived carbon monoxide to fight against lung cancer.

Yujia Fang, Jianjun Yang, Xiayi Liang, Jing Wu, Mengqing Xie, Kun Zhang, Chunxia Su

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nanobiotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yujia FangDepartment of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, School of Medicine, Tongji University, Shanghai, 200092, China.
Jianjun YangCentral Laboratory and Department of Orthopaedics, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, No. 301 Yan-Chang-Zhong Road, Shanghai, 200072, China.
Xiayi LiangCentral Laboratory and Department of Orthopaedics, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, No. 301 Yan-Chang-Zhong Road, Shanghai, 200072, China.
Jing WuDepartment of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, School of Medicine, Tongji University, Shanghai, 200092, China.
Mengqing XieDepartment of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, School of Medicine, Tongji University, Shanghai, 200092, China.
Kun ZhangCentral Laboratory and Department of Orthopaedics, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, No. 301 Yan-Chang-Zhong Road, Shanghai, 200072, China. zhang1986kun@126.com.
Chunxia SuDepartment of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, School of Medicine, Tongji University, Shanghai, 200092, China. susu_mail@126.com.

Funding

National Natural Science Foundation of China 82072568Shanghai Shenkang Hospital Development Center SHDC2022CRD048
6 · The paper itself

Abstract

Reactive oxygen species (ROS)-associated anticancer approaches usually suffer from two limitations, i.e., insufficient ROS level and short ROS half-life. Nevertheless, no report has synchronously addressed both concerns yet. Herein, a multichannel actions-enabled nanotherapeutic platform using hollow manganese dioxide (H-MnO

Indexed as

Carbon MonoxideLung NeoplasmsManganese CompoundsOxidesPorphyrinsReactive Oxygen SpeciesA549 CellsAnimalsCell Line, TumorChlorophyllidesHumansHydrogen PeroxideMiceMice, Inbred BALB CMice, NudeCarbon MonoxideChlorophyllidesHydrogen PeroxideManganese Compoundsmanganese dioxideOxidesphytochlorinPorphyrinsReactive Oxygen SpeciesCarbon monoxideCascade catalysisLong half-lifeLung cancerReactive oxygen species

Identifiers

PMID39014402
PMCPMC11253342

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.